Page 2,849«..1020..2,8482,8492,8502,851..2,8602,870..»

Maven Semantic: Embryonic Stem Cells Research Database

Posted: February 24, 2012 at 5:42 pm

DUBLIN--(BUSINESS WIRE)--

Maven Semantic (http://www.mavensemantic.com) announces updates to their Embryonic Stem Cells research database.

The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.

The database currently tags 27,000 individuals working in Embryonic Stem Cells. http://bit.ly/zc0cU4.

Top 10 Countries for Embryonic Stem Cells Research (ranked by number of senior researchers)

Leading organisations in Embryonic Stem Cells research include:

Albert Einstein College of Medicine Baylor College of Medicine Brigham and Women's Hospital California Institute of Technology Chinese Academy of Sciences Cornell University Dana-Farber Cancer Institute Duke University Medical Center Fred Hutchinson Cancer Research Center Genome Institute of Singapore Harvard Medical School Howard Hughes Medical Institute Hubrecht Laboratory Indiana University School of Medicine Institut Pasteur Institute for Frontier Medical Sciences Institute of Human Genetics Institute of Molecular Embryology and Genetics Johns Hopkins University School of Medicine Karolinska Institute Keio University School of Medicine Lund University Mount Sinai Hospital New York University School of Medicine Seoul National University University College London University of Cambridge University of Chicago University of Massachusetts Medical School University of Michigan University of Pennsylvania University of Toronto University of Tsukuba Weill Medical College of Cornell University Zhejiang University

The database also includes pharmaceutical companies, biotech companies, CROs, hospitals, government labs and other organisations active in the Embryonic Stem Cells research field.

Sample companies in database include:

AgResearch Ltd Amgen Inc Axiogenesis AG Cellartis AB Cellular Dynamics International, Inc Chugai Pharmaceutical Co., Ltd DNAVEC Corporation ES Cell International Pte Ltd F. Hoffmann-La Roche Ltd Genentech, Inc GENPHARM INTERNATIONAL, INC Geron Corporation Hayashibara Biochemical Laboratories, Inc Illumina, Inc Ingenium Pharmaceuticals AG Invitrogen Corporation Japan Science and Technology Corp KENNEDY KRIEGER, INC Regeneron Pharmaceuticals, Inc

What is Maven:

- Largest database of international medical professionals, with over 6,000,000 people and over 500,000 medical organisations;

- All records are downloadable to excel or in-house database, with email, postal address and phone contacts;

- Profile and segment the entire database using over 47,000 diseases and therapeutic areas

For more information visit http://www.mavensemantic.com/

Read more here:
Maven Semantic: Embryonic Stem Cells Research Database

Posted in Stem Cell Research | Comments Off on Maven Semantic: Embryonic Stem Cells Research Database

ISSCR Honors Stem Cell Research Pioneer with Prestigious McEwen Award for Innovation

Posted: February 24, 2012 at 5:42 pm

Newswise — The International Society for Stem Cell Research (ISSCR) is pleased to announce the winner of the 2012 McEwen Award for Innovation, a coveted prize in the field of stem cell research and regenerative medicine. The 2012 recipient is Rudolf Jaenisch, MD, Founding Member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology in recognition of his pioneering discoveries in the areas of genetic and epigenetic control of development in mice that directly impact the future potential of embryonic stem cells and induced pluripotent stem cells for therapeutic utility.

The McEwen Award for Innovation is supported by the McEwen Centre for Regenerative Medicine in Toronto, Ontario, Canada. The $100,000 award honors original thinking and groundbreaking research pertaining to stem cells or regenerative medicine that opens new avenues of exploration towards the understanding or treatment of human disease or affliction.

“Rudolf Jaenisch has consistently contributed new and groundbreaking discoveries to stem cell biology and regenerative medicines that have changed the way stem cell research is conducted, said Fred H. Gage, PhD, ISSCR President. “Importantly, Rudolf not only has an uncanny sense of the next big question, but also conducts his experiments with such thoughtful and critical experimental design that his results have an immediate impact. This critical attention to detail and experimental design has greatly benefited the many gifted students that have passed through his lab and now populate many of the major stem cell centers throughout the world. Rudolf is very deserving of this award.”

Winner of the inaugural McEwen Award for Innovation in 2011, Shinya Yamanaka, MD, PhD, ISSCR President-Elect agrees. “Dr. Rudolf Jaenisch has always been on the cutting-edge of our field and his research has been a source of inspiration not only for myself, but has influenced the careers of some of our most esteemed colleagues.”

Dr. Jaenisch will be presented with the award at the ISSCR 10th Annual Meeting, in Yokohama, Japan, on Wednesday, June 13, 2012.
***
The International Society for Stem Cell Research is an independent, nonprofit membership organization established to promote and foster the exchange and dissemination of information and ideas relating to stem cells, to encourage the general field of research involving stem cells and to promote professional and public education in all areas of stem cell research and application.

Comment/Share

Read more from the original source:
ISSCR Honors Stem Cell Research Pioneer with Prestigious McEwen Award for Innovation

Posted in Stem Cell Research | Comments Off on ISSCR Honors Stem Cell Research Pioneer with Prestigious McEwen Award for Innovation

ISSCR Honors Stem Cell Research Pioneer with Prestigious McEwen Award for Innovation

Posted: February 24, 2012 at 2:22 am

Newswise — The International Society for Stem Cell Research (ISSCR) is pleased to announce the winner of the 2012 McEwen Award for Innovation, a coveted prize in the field of stem cell research and regenerative medicine. The 2012 recipient is Rudolf Jaenisch, MD, Founding Member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology in recognition of his pioneering discoveries in the areas of genetic and epigenetic control of development in mice that directly impact the future potential of embryonic stem cells and induced pluripotent stem cells for therapeutic utility.

The McEwen Award for Innovation is supported by the McEwen Centre for Regenerative Medicine in Toronto, Ontario, Canada. The $100,000 award honors original thinking and groundbreaking research pertaining to stem cells or regenerative medicine that opens new avenues of exploration towards the understanding or treatment of human disease or affliction.

“Rudolf Jaenisch has consistently contributed new and groundbreaking discoveries to stem cell biology and regenerative medicines that have changed the way stem cell research is conducted, said Fred H. Gage, PhD, ISSCR President. “Importantly, Rudolf not only has an uncanny sense of the next big question, but also conducts his experiments with such thoughtful and critical experimental design that his results have an immediate impact. This critical attention to detail and experimental design has greatly benefited the many gifted students that have passed through his lab and now populate many of the major stem cell centers throughout the world. Rudolf is very deserving of this award.”

Winner of the inaugural McEwen Award for Innovation in 2011, Shinya Yamanaka, MD, PhD, ISSCR President-Elect agrees. “Dr. Rudolf Jaenisch has always been on the cutting-edge of our field and his research has been a source of inspiration not only for myself, but has influenced the careers of some of our most esteemed colleagues.”

Dr. Jaenisch will be presented with the award at the ISSCR 10th Annual Meeting, in Yokohama, Japan, on Wednesday, June 13, 2012.
***
The International Society for Stem Cell Research is an independent, nonprofit membership organization established to promote and foster the exchange and dissemination of information and ideas relating to stem cells, to encourage the general field of research involving stem cells and to promote professional and public education in all areas of stem cell research and application.

Comment/Share

See the article here:
ISSCR Honors Stem Cell Research Pioneer with Prestigious McEwen Award for Innovation

Posted in Regenerative Medicine | Comments Off on ISSCR Honors Stem Cell Research Pioneer with Prestigious McEwen Award for Innovation

Is ‘in vitro meat’ moving closer to the menu?

Posted: February 23, 2012 at 8:37 pm

VANCOUVER, British Columbia -- In a laboratory in the Netherlands, stem cells from cows are being grown into what researcher Mark J. Post says will be the first so-called "test-tube burger" -- comprising the tiny pieces of tissue-engineered, or "in vitro," meat -- that he and his colleagues aim to cook and taste as early as this October.

By this summer, California researcher Patrick O. Brown says, a company he's helped start will bring to market a revolutionary new plant-based substitute for a meat or dairy food -- he's not yet sharing specifics -- that "can't be distinguished from the animal product it replaces, even by hard-core foodies."

The scientists are on the leading edge of a movement to dramatically change how the world grows and consumes meat, something they say must happen, one way or another.

"Animal farming is by far the biggest ongoing global environmental catastrophe," Mr. Brown said Sunday at a news briefing for journalists from around the world at the annual meeting of the American Association for the Advancement of Science, attended by some 5,000 delegates and 700 media people in Vancouver.

He and Mr. Post were part of a panel of four experts who later that day presented a symposium titled, "Meat without Animals: Test-tube Burgers and More." It was provocative enough that the Times of London broke a news embargo to publish something on it that morning, and bits of the story have been broadcast this week as far and wide as the local TV news in Pittsburgh.

The issue certainly is food for thought.

Mr. Brown, a biochemist at the Stanford University School of Medicine, wants to see a world without animal farming, because "in every conceivable way, it's inefficient and destructive."

Inefficient, in that it takes many pounds of grains, and many, many gallons of water, to make a typical quarter-pounder. Destructive, he said, citing sobering United Nations statistics, that show animal farming takes up about 30 percent of the Earth's land, accounts for more than 18 percent of greenhouse gas emissions, is the largest source of water pollution and the biggest threat to biodiversity.

Meanwhile, the world's appetite for meat is expected to double by 2050.

Mr. Brown called animal agriculture, mostly unchanged for centuries, as "a sitting duck for a disruptive technology."

That's why, with backing from a Silicone Valley venture capital firm, he's launched two startups to create and market alternative foods that, like him, are vegetarian.

Of course, the market already has plenty of meat substitutes and non-dairy "cheeses," but he says they're not very good and they're expensive, and they're marketed to people who've already chosen to be vegetarian or vegan for health or ethical reasons, not to the mainstream.

The products he plans will compete head-on with animal products by being "high-value, protein-rich, nutrient-dense human foods that appeal to consumers" -- stand-ins for everything from bacon to cheddar.

Professor Post of Maastricht University said that he hopes Mr. Brown and others are able to fix the problems of animal agriculture with plants. But because he believes many people want real meat, his research is about producing that in a more efficient, less environmentally degrading way.

Cows are only about 15 percent efficient at making meat from grains and other foods, he said. Making beef under more controlled conditions could feed a lot more people while using fewer resources, saving the grains for human consumption as food as well as biofuel. (Their aim is to grow meat with vegetable-based nutrients, perhaps involving algae.)

With backing of $330,000 from a "reputable," non-food-industry funder he's not yet identifying, his team is working to grow enough muscle cells to show that "cultured meat" is possible.

Already, they've grown bovine stem cells into tiny strips about an inch long and 2/100ths of an inch thick.

They'll need thousands of these to make a burger (the golf-ball-sized goal sounds more like a slider, and an expensive one at that). But that's just one of many challenges.

Growing stem cells happens in labs all over the world, including Pittsburgh, where some researchers envision being able to make replacement organs for humans.

Bits for ground beef, the most popular meat in the U.S., look to be relatively easy. (Mr. Post got laughs when recounting how they started with pig cells, planning to make sausage, which can be "hardly recognizable as a meat product" anyway).

But muscle cells on an animal grow because of conditions that scientists have to figure out how to create in the petri dish. Mr. Post described using electric current to "exercise" the cow muscle cells, and treatments ranging from administering caffeine to withholding light to get them to make more myoglobin, which gives meat its red color.

"Right now, it's sort of a pinkish-yellowish," he told journalists. "The color is an interesting issue."

But, as he said later, it's also a scientifically controllable one. His part of the talk touched on possibilities including lowering the saturated fat and cholesterol of various meats, even creating custom combinations of meats.

His Powerpoint presentation illustrated the ultimate goal -- making "big slabs of meat" -- which were fancifully depicted as octagonal steaks, on round ceramic "bones."

Even if he does taste that burger this fall, cultured filet mignons are a long ways off. They will be expensive, as will all the research it'll take.

"But what's the cost of traditional meat production?" asked Nicholas Genovese, a visiting scholar at the University of Missouri-Columbia who organized the symposium. He includes in that the costs of dealing with outbreaks of food-borne illness and other human health woes associated with animal foods.

One of the issues he stresses is the ethical one of millions of animals being killed. His research, in fact, is funded by a grant from the People for the Ethical Treatment of Animals, which in 2008 offered a $1 million reward for the first researchers to make in vitro chicken meat, indistinguishable from the "real" deal, and sell it to the public by June 30, 2012.

That offer stands and might be extended at a PETA meeting in Los Angeles in April, PETA President Ingrid Newkirk said in a phone interview from Washington, D.C., last week. "Originally, we thought we'd never have to pay out," she said. "Nobody had heard of [in vitro meat]. We wanted to boot it into the public consciousness."

Now, she says, "We're feeling very good" about the research progress that's been made. "If this allows them to get rid of cruelty to animals, fabulous."

She's well aware that the idea of in vitro meat can stir strong reactions from everyone from Midwest farmers to home cooks, but says, "Everybody fears change," and points out that many foods such as soy milk were once little known.

The AAAS panelists included KeShun Liu, a U.S. Department of Agriculture researcher who talked about the next generation of extruded meat "analogs" that mimic the fibers of real chicken and turkey. (He said to look for products soon from Maryland's Savage River Farms).

The panelists agreed they're not advocating for legislation or subsidies; they're just working for alternatives for consumers.

Some acceptance of these new alternatives may be a matter of language. At the AAAS meeting, Mr. Genovese stressed, "In vitro meat will never be produced in the 'lab.' " As beer is made in a brewery, he has proposed calling meat production facilities of the future "carneries."

Bob Batz Jr.: bbatz@post-gazette.com or 412-263-1930.

First published on February 23, 2012 at 12:00 am

Continued here:
Is 'in vitro meat' moving closer to the menu?

Posted in Stem Cells | Comments Off on Is ‘in vitro meat’ moving closer to the menu?

Japanese researchers find stem cells reduce monkeys’ Parkinson’s symptoms

Posted: February 23, 2012 at 8:37 pm

Japanese researchers have been able to improve the symptoms of Parkinson's disease in monkeys by transplanting nerve cells derived from embryonic stem cells into their brains, the team has announced.

The finding is the world's first reported success of its kind with a primate, according to the research team led by associate professor Jun Takahashi of Kyoto University's Institute for Frontier Medical Sciences. It has been released in the online edition of US journal Stem Cells.

After the transplant, the monkeys, which had been almost unable to move, showed improvements in their symptoms to the point where they became able to walk on their own, the team said.

Parkinson's disease is a neurological illness believed to be caused by a deficit of the neurotransmitter dopamine in the brain.

Embryonic stem cells, which have the potential to become almost any type of tissue, are harvested from inside a blastocyst, which develops from a mammalian egg cell about a week after it is fertilised.

Takahashi's research team used the embryonic stem cells to cultivate a cell mass in which 35 per cent of the cells were dopamine-producing neurons.

These neurons then were transplanted into the four crab-eating monkeys, whose conditions were observed over a one-year period.

According to the study, the monkeys exhibited reduced shaking of their limbs half a year later. They had remained nearly motionless inside their cages all day long before the transplant, but the improvement of their symptoms eventually enabled them to occasionally walk around the cages.

The research team confirmed that normal nerve cells had been created in their brains.

The finding could mark a major breakthrough for applying embryonic stem cells in clinical settings, experts said. The Health, Labour and Welfare Ministry has been encouraging researchers to study the clinical applications of not only stem cells, but also induced pluripotent stem cells, which also can grow into many kinds of human cells.

Takahashi's team has already performed experiments to transplant iPS cells into monkeys' brains.

"We'll make further efforts to enhance the safety of these cell transplants," Takahashi said. "And we hope to start clinical application studies as early as three years from now."

Read more from the original source:
Japanese researchers find stem cells reduce monkeys' Parkinson's symptoms

Posted in Stem Cells | Comments Off on Japanese researchers find stem cells reduce monkeys’ Parkinson’s symptoms

Stem Cell Action Coalition Opposes Virginia Personhood Bill

Posted: February 23, 2012 at 4:44 pm

To: HEALTH, MEDICAL AND POLITICAL EDITORS

WASHINGTON, Feb. 23, 2012 /PRNewswire-USNewswire/ -- The Stem Cell Action Coalition opposes Virginia House Bill No.1, the so-called Virginia "personhood bill." The Virginia Senate Committee on Education and Health is scheduled to take the matter up this week.

The language of the personhood bill states, in part, that the laws of Virginia "shall be interpreted and construed to acknowledge on behalf of unborn children at every stage of development all of the rights, privileges and immunities available to other persons, citizens and residents." The bill further states "unborn children shall include the offspring of human beings from the moment of conception until birth at every stage of biological development."

HB 1 arguably would apply to every aspect of Virginia law thus profoundly impacting inheritance, adoption, guardianship, civil and criminal liability by according the same rights as adults and children to a single cell.

The personhood bill would surely interfere with reproductive and related rights of women and couples along several fronts. These interferences include making it exceedingly difficult for couples in Virginia to seek in vitro fertilization as a means of creating families and donating for research IVF-created embryos not needed for implantation or not sufficiently healthy for implantation. Moreover, the law would prevent the pursuit of medical research in Virginia that utilizes human embryonic stem cells.

In this twisted new world, Virginia researchers deriving embryonic stem cells from donated embryos might be charged with capital crimes, even murder. Couples donating embryos to research might be designated as accessories to these crimes. Microscopic embryos, consisting of a few cells in lab dishes or frozen in IVF clinics might be designated as wards of the state and by mandate have legal guardians appointed on their behalf.

Human embryonic stem cell research has been described by scientists as the "gold standard" for those seeking to develop cures based on stem cell technology for many diseases and maladies such as Parkinson's, ALS, diabetes, MS, macular degeneration and other causes of blindness, spinal cord injuries, and other medical conditions for which there is no known cure.

Bernard Siegel, J.D., spokesperson for the Coalition and executive director of the Genetics Policy Institute commented, "It is a sad day indeed when the Commonwealth of Virginia should become an outpost for extremism by impeding potentially lifesaving scientific research. Thomas Jefferson would be appalled. The wise voters of Colorado (twice) and Mississippi overwhelmingly rejected personhood amendments to their state constitutions.

The profound implications of the personhood bill cannot be wished away by its sponsors. Passage of this bill would be an affront to couples trying to avail themselves of modern infertility treatments, stem cell researchers targeting cures and to all Virginians suffering from chronic and life threatening disease. Passage of HB 1 is akin to crushing hope.

Human embryonic stem cell research holds the promise of discovering the root causes of disease, serves as a tool for drug discovery, and will surely lead to regenerative medicines and cell therapies for repairing or replacing damaged tissues and organs.

Microscopic cells in a lab dish, that by a couples' decision, will never be implanted in a womb, should not be defined as 'people'," Siegel continued.

HB 1 represents a concerted move by opponents of all forms of early termination of pregnancy and medical research involving human embryos to attempt to pass laws to define "person" as the being that comes into existence at conception. In addition to Virginia, similar efforts to pass "personhood" legislation are underway in Oklahoma, Mississippi and in other states.

The Stem Cell Action Coalition has 75 nonprofit affiliated organizations including patient groups, medical philanthropies, scientific and medical societies and public interest organizations all dedicated to advancing scientifically meritorious and ethically responsible research.

The Stem Cell Action Coalition serves as an engine to unite the pro-cures community. It recognizes that human embryonic stem cell research must be a national public health priority at all branches and levels of government, not only as a matter of the medical health of the individuals who comprise the United States, but also as a matter of national financial health. The Coalition sponsors a web site http://www.stemcellaction.org and can be found on Twitter @StemCellAction and on Facebook at http://www.facebook.com/stemcellaction.

SOURCE The Stem Cell Action Coalition

-0-

Read the original post:
Stem Cell Action Coalition Opposes Virginia Personhood Bill

Posted in Stem Cell Research | Comments Off on Stem Cell Action Coalition Opposes Virginia Personhood Bill

Stem cells offer hope for blind – Video

Posted: February 23, 2012 at 8:45 am

24-01-2012 12:40 Mon, Jan 23: It's an experimental breakthrough treatment for macular degeneration. Jennifer Tryon explains how embryonic stem cells helped two blind people see again.

Read more:
Stem cells offer hope for blind - Video

Posted in Stem Cell Videos | Comments Off on Stem cells offer hope for blind – Video

UM human embryonic stem cell line placed on national registry – Video

Posted: February 23, 2012 at 8:45 am

17-02-2012 08:27 The University of Michigan's first human embryonic stem cell line will be placed on the US National Institutes of Health's registry, making the cells available for federally-funded research. It is the first of the stem cell lines derived at the University of Michigan to be placed on the registry. The line, known as UM4-6, is a genetically normal line, derived in October 2010 from a cluster of about 30 cells removed from a donated five-day-old embryo roughly the size of the period at the end of this sentence. That embryo was created for reproduction but was no longer needed for that purpose and was therefore about to be discarded.

Read the original here:
UM human embryonic stem cell line placed on national registry - Video

Posted in Stem Cell Videos | Comments Off on UM human embryonic stem cell line placed on national registry – Video

Buzz:Test tube beef – Video

Posted: February 23, 2012 at 8:45 am

21-02-2012 05:39 (WTNH)-- Would you be willing to eat a burger that was grown in a test tube? Researchers say they have come up with a way to grow meat in a lab using animal stem cells.

View post:
Buzz:Test tube beef - Video

Posted in Stem Cell Videos | Comments Off on Buzz:Test tube beef – Video

Verastem to Present at RBC and Citi Healthcare Conferences

Posted: February 23, 2012 at 8:45 am

CAMBRIDGE, Mass.--(BUSINESS WIRE)--

Verastem, Inc., (NASDAQ: VSTM - News) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced presentations at two upcoming investment conferences. The Verastem presentation details are as follows:

2012 RBC Capital Markets’ Global Healthcare Conference on Tuesday, February 28, 2012 at 4:35 p.m. (ET) at the New York Palace Hotel in New York City. Citi 2012 Global Healthcare Conference on Wednesday, February 29, 2012 at 9:30 a.m. (ET) at the Waldorf Astoria Hotel in New York City.

Webcasts of the presentations can be accessed by visiting the investors section of the company’s website at http://www.verastem.com. A replay of the webcasts will be archived on the Verastem website for two weeks following each presentation date, respectively.

About Verastem, Inc.

Verastem, Inc. (NASDAQ: VSTM - News) is a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is translating discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer. For more information please visit http://www.verastem.com.

Forward-looking statements:

Any statements in this press release about future expectations, plans and prospects for the Company constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.

Read more:
Verastem to Present at RBC and Citi Healthcare Conferences

Posted in Stem Cell Videos | Comments Off on Verastem to Present at RBC and Citi Healthcare Conferences

Page 2,849«..1020..2,8482,8492,8502,851..2,8602,870..»